• 검색 결과가 없습니다.

Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:240-7)

N/A
N/A
Protected

Academic year: 2021

Share "Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:240-7)"

Copied!
2
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

참조

관련 문서

[r]

The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new‑onset type 2

Therefore, we investigated the association between migraine and major cardiovascular outcomes, including myocardial infarction (MI), ischemic stroke (IS), cardio-

Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.. Mindfulness-based therapies in the treatment

In the present study, the ALO-PIO group showed greater improvement in various parameters of glycemic variability as- sessed by CGM, than the GLIM group, although there was

Although screening or prediction of many medical conditions can benefit public health, early identification of in- dividuals at risk for type 2 diabetes mellitus (DM) and

6 Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul,..

When comparing adverse pregnancy outcomes according to GWG from the second to the third trimester, the proportion of any adverse maternal outcomes, cesarean delivery, and